NYSEAMERICAN:MYO - Myomo Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.82 +0.11 (+6.43 %) (As of 12/13/2018 04:17 AM ET)Previous Close$1.71Today's Range$1.61 - $1.8552-Week Range$1.60 - $5.63Volume253,500 shsAverage Volume394,719 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts. Receive MYO News and Ratings via Email Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:MYO Previous Symbol CUSIPN/A Webmyomo.com Phone+1-617-9969058 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees22 Outstanding Shares12,440,000Market Cap$0.00 OptionableNot Optionable Myomo (NYSEAMERICAN:MYO) Frequently Asked Questions What is Myomo's stock symbol? Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO." How were Myomo's earnings last quarter? Myomo Inc (NYSEAMERICAN:MYO) released its earnings results on Monday, November, 5th. The company reported ($0.21) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.20) by $0.01. The business had revenue of $0.61 million for the quarter, compared to analyst estimates of $0.82 million. View Myomo's Earnings History. When is Myomo's next earnings date? Myomo is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Myomo. What price target have analysts set for MYO? 2 analysts have issued 12 month price objectives for Myomo's shares. Their predictions range from $7.00 to $12.00. On average, they expect Myomo's stock price to reach $9.50 in the next twelve months. This suggests a possible upside of 422.0% from the stock's current price. View Analyst Price Targets for Myomo. What is the consensus analysts' recommendation for Myomo? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Myomo. Has Myomo been receiving favorable news coverage? News coverage about MYO stock has been trending neutral recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Myomo earned a news impact score of 0.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the stock's share price in the immediate future. Are investors shorting Myomo? Myomo saw a decrease in short interest during the month of November. As of November 30th, there was short interest totalling 813,452 shares, a decrease of 1.9% from the November 15th total of 829,262 shares. Based on an average trading volume of 77,403 shares, the days-to-cover ratio is presently 10.5 days. Currently, 7.9% of the company's shares are sold short. View Myomo's Current Options Chain. Who are some of Myomo's key competitors? Some companies that are related to Myomo include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Biosig Technologies (BSGM), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD) and Ellex Medical Lasers (ELXMF). Who are Myomo's key executives? Myomo's management team includes the folowing people: Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 63)Ms. Davie Mendelsohn RN, VP of Sales & Clinical Services (Age 64)Mr. Jonathan Naft, VP & GM (Age 53)Mr. Ralph A. Goldwasser, Chief Financial Officer (Age 70)Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 68) How do I buy shares of Myomo? Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Myomo's stock price today? One share of MYO stock can currently be purchased for approximately $1.82. What is Myomo's official website? The official website for Myomo is http://myomo.com/. How can I contact Myomo? Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company can be reached via phone at +1-617-9969058. MarketBeat Community Rating for Myomo (NYSEAMERICAN MYO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 96 (Vote Outperform)Underperform Votes: 91 (Vote Underperform)Total Votes: 187MarketBeat's community ratings are surveys of what our community members think about Myomo and other stocks. Vote "Outperform" if you believe MYO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/13/2018 by MarketBeat.com StaffFeatured Article: How accurate is the Rule of 72?